Skip to content
sellWeak

Ronald Leroy Langham JR sold $5,586 of EHAB

EVP Clinical Excel. & Strategy at Enhabit, Inc.. 634 shares at an average of $8.81, traded Mar 1, 2024, filed Mar 5, 2024.

Warning score
15
Value
$5,586
634 shares
Holdings after
57,164
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $6k at market
    0
  • Share of holdings sold
    Sold 1.1% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001803737-24-000032, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 1, 2024AGrant or award
Common Stock
+15,027$8.81$132k57,798Mar 5, 2024
Mar 1, 2024SOpen-market sale
Common Stock
-634$8.81$5,58657,164Mar 5, 2024

Related signals

Other insiders at Enhabit, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
EHABsell 2
Enhabit, Inc.
Collin McQuiddy
Chief Accounting Officer
$19k
1,403 shares
-26%
11Weak
EHABsell 210b5-1
Enhabit, Inc.
Julie Diane Jolley
EVP of Home Health Operations
$76k
5,586 shares
-4%
33Weak
EHABbuy
Enhabit, Inc.
Ryan Solomon
Chief Financial Officer
$76k
10,000 shares
+5%
35Weak
EHABsell
Enhabit, Inc.
Collin McQuiddy
Chief Accounting Officer
$9,404
1,096 shares
-100%
34Weak
EHABbuy 2
Enhabit, Inc.
Jeffrey Bolton
director
$35k
4,000 shares
+4%
40Moderate
EHABbuy 2
Enhabit, Inc.
Stuart M McGuigan
director
$132k
15,000 shares
+47%
26Weak
EHABbuy
Enhabit, Inc.
Jeffrey Bolton
director
$77k
10,000 shares
+12%
29Weak
EHABbuy
Enhabit, Inc.
Jeffrey Bolton
director
$40k
5,000 shares
+7%
30Weak
EHABbuy
Enhabit, Inc.
Jeffrey Bolton
director
$59k
7,000 shares
+10%
43Moderate
EHABbuy 2
Enhabit, Inc.
Jeffrey Bolton
director
$83k
10,000 shares
+24%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ronald Leroy Langham JR sold $5,586 of EHAB | InsiderTell